Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 9, Issue 5, 2007, Pages 355-364

  Smith, Timothy R ^a   Philipp, Thomas ^a   Vaisse, Bernard ^a   Bakris, George L ^a   Wernsing, Margaret ^a   Yen, Joseph ^a   Glazer, Robert ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE; VALSARTAN;

AGE; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEGRO; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 34948883404     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2007.06689.x     Document Type: Article

References (0)